| Responsible innovation across borders: tensions, paradoxes and possibilities P Macnaghten, R Owen, J Stilgoe, B Wynne, A Azevedo, A de Campos, ... Journal of Responsible Innovation 1 (2), 191-199, 2014 | 239 | 2014 |
| Taking roles in interdisciplinary collaborations: reflections on working in post-ELSI spaces in the UK synthetic biology community AS Balmer, J Calvert, C Marris, S Molyneux-Hodgson, E Frow, M Kearnes, ... Science & Technology Studies 28 (3), 3-25, 2015 | 184 | 2015 |
| Five rules of thumb for post-ELSI interdisciplinary collaborations AS Balmer, J Calvert, C Marris, S Molyneux-Hodgson, E Frow, M Kearnes, ... Journal of Responsible Innovation 3 (1), 73-80, 2016 | 103 | 2016 |
| Drawing a line: Setting guidelines for digital image processing in scientific journal articles EK Frow Social Studies of Science 42 (3), 369-392, 2012 | 57 | 2012 |
| Building a biofoundry MB Holowko, EK Frow, JC Reid, M Rourke, CE Vickers Synthetic Biology 6 (1), ysaa026, 2021 | 55 | 2021 |
| A roadmap for gene drives: using institutional analysis and development to frame research needs and governance in a systems context J Kuzma, F Gould, Z Brown, J Collins, J Delborne, E Frow, K Esvelt, ... Journal of Responsible Innovation 5 (sup1), S13-S39, 2018 | 55 | 2018 |
| Sustainability and anticipatory governance in synthetic biology A Wiek, D Guston, E Frow, J Calvert International Journal of Social Ecology and Sustainable Development (IJSESD …, 2012 | 54 | 2012 |
| The politics of plants E Frow, D Ingram, W Powell, D Steer, J Vogel, S Yearley Food Security 1, 17-23, 2009 | 50 | 2009 |
| Bigger, faster, better? Rhetorics and practices of large-scale research in contemporary bioscience G Davies, E Frow, S Leonelli BioSocieties 8, 386-396, 2013 | 46 | 2013 |
| Tools for anti‐inflammatory drug design: In vitro models of leukocyte migration EK Frow, J Reckless, DJ Grainger Medicinal research reviews 24 (3), 276-298, 2004 | 45 | 2004 |
| ‘Can simple biological systems be built from standardized interchangeable parts?’Negotiating biology and engineering in a synthetic biology competition E Frow, J Calvert Engineering Studies 5 (1), 42-58, 2013 | 43 | 2013 |
| Thrombospondin 1 does not activate transforming growth factor β1 in a chemically defined system or in smooth-muscle-cell cultures DJ GRAINGER, EK FROW Biochemical Journal 350 (1), 291-298, 2000 | 40 | 2000 |
| Making big promises come true? Articulating and realizing value in synthetic biology EK Frow BioSocieties 8, 432-448, 2013 | 37 | 2013 |
| Classifying, constructing, and identifying life: standards as transformations of “the biological” A Mackenzie, C Waterton, R Ellis, EK Frow, R McNally, L Busch, B Wynne Science, technology, & human values 38 (5), 701-722, 2013 | 37 | 2013 |
| 12 In Images We Trust? Representation and Objectivity in the Digital Age EK Frow Representation in scientific practice revisited, 249, 2014 | 35 | 2014 |
| Opening up the future (s) of synthetic biology E Frow, J Calvert Futures 48, 32-43, 2013 | 33 | 2013 |
| Mapping research and governance needs for gene drives J Delborne, J Kuzma, F Gould, E Frow, C Leitschuh, J Sudweeks Journal of Responsible Innovation 5 (sup1), S4-S12, 2018 | 25 | 2018 |
| From “experiments of concern” to “groups of concern”: Constructing and containing citizens in synthetic biology E Frow Science, Technology, & Human Values 45 (6), 1038-1064, 2020 | 22 | 2020 |
| Characterizing direct-to-consumer stem cell businesses in the southwest United States EK Frow, DA Brafman, A Muldoon, L Krum, P Williams, B Becker, ... Stem Cell Reports 13 (2), 247-253, 2019 | 20 | 2019 |
| Guest editorial: synthetic biology: making biology into an engineering discipline P Schyfter, E Frow, J Calvert Engineering Studies 5 (1), 1-5, 2013 | 19 | 2013 |
